Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy vs Chemoradiotherapy in p53-mutated Endometrial Cancer
NCT05489848Phase 3Not yet recruiting
- Sponsor
- Fudan University
- Start
- Aug 2022
- Primary completion
- Aug 2028
- Modality
- DNA Intercalators/Alkylators, Cytokines & Interferons, Fc-Fusion Proteins
01
Overview
A Phase 3 trial of Paclitaxel Micelles for Injection, carboplatin in endometrial cancer (EC), sponsored by Fudan University. Planned start Aug 2022; status: not yet recruiting.
02
Drugs
Paclitaxel Micelles for Injectioncarboplatin
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT05489848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05489848.